Dachaigh › Seasamh Insulin › California
Sgrùdaidhean clionaigeach Seasamh Insulin ann an California
Tha 11 sgrùdaidhean airson Seasamh Insulin a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
Teacsa sgrùdaidh oifigeil (Beurla)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
A’ fastadhSgrùdadh amharc
Aoisean 8 gu 35 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
A’ fastadhÌre 2
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 25 Ògmh 2026 · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
A’ fastadhÌre 2
Aoisean 21 gu 85 · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
A’ fastadhÌre 1
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 28 Gibl 2026 · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Gibl 2026 · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
A’ fastadhÌre 4Fàilte do shaor-thoilich fhallain
Aoisean 30 gu 70 · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT07220694Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 35 gu 65 · Gach gnè · Air ùrachadh 4 Dùbh 2024 · NCT05165706Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 4 Dùbh 2024 · NCT05833217Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.